根治性前列腺切除术后残留良性前列腺腺体组织与术后可检测血清PSA无关
该研究纳入2004至2018年间因局限性前列腺癌行根治性前列腺切除术的1082例患者,其中249例(23%)手术病理报告切缘良性腺体组织(BGM)。中位随访7年时,29%出现可检测PSA,11%发生生化复发(BCR)。多因素分析显示BGM与可检测PSA、BCR及从可检测PSA进展至BCR或挽救治疗均无独立关联。
要点
- 根治性前列腺切除术后切缘良性腺体组织(BGM)发生率约23%。
- BGM与可检测PSA、生化复发(BCR)及进展风险无独立关联。
- 年轻、双侧神经保留手术和机器人入路与BGM存在相关,但切缘恶性肿瘤无关。
核心结论
- 根治性前列腺切除术中切缘良性腺体组织(BGM)的存在与切缘恶性肿瘤、可检测PSA、生化复发(BCR)或可检测PSA后的进展风险增加无关。
研究设计与样本
- 回顾性队列研究,纳入2004至2018年间因局限性前列腺癌行根治性前列腺切除术的1082例患者,术后PSA不可检测且手术病理报告BGM状态。
主要发现
- 249例(23%)手术标本存在BGM。
- 术后7年,29%出现可检测PSA(>0.03 ng/ml),11%发生BCR(≥0.2 ng/ml)。
- 在达到可检测PSA的亚组中,79%在7年内出现进展。
- 多因素Cox回归显示BGM状态与可检测PSA、BCR及从可检测PSA进展至BCR或挽救治疗均无独立关联。
- 年轻年龄、双侧神经保留手术和机器人入路与BGM存在相关,而切缘恶性肿瘤与BGM无关。
临床怎么用
- 术后病理报告切缘良性腺体组织(BGM)时,不应视为增加生化复发或进展风险的独立危险因素。
- 对于存在BGM的患者,术后PSA监测和随访策略可参照常规路径,无需因BGM本身加强干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine if benign glandular tissue at the surgical margin (BGM) is associated with detectable prostate specific antigen (PSA) and/or biochemical recurrence (BCR) after radical prostatectomy (RP). MATERIALS AND METHODS: Participants underwent RP for localized prostate cancer between 2004 and 2018. Regression analysis was used to identify demographic, clinical and surgical factors associated with the likelihood of BGM presence on surgical pathology. Oncologic outcomes included detectable PSA (>0.03 ng/ml), BCR (≥0.2 ng/ml) and progression to BCR or salvage treatment after detectable PSA. Life tables and Cox proportional hazards regression models were used to determine the association of BGM and risk of oncologic outcomes. RESULTS: A total of 1,082 men underwent RP for localized prostate cancer with BGM reported on surgical pathology and an undetectable postoperative PSA. BGM was present on 249 (23%) specimens. Younger age, bilateral nerve sparing surgery and robotic approach were associated with presence of BGM while malignancy at the surgical margin (MSM) was not. At 7 years after RP, 29% experienced detectable PSA and 11% had BCR. In the subgroup of men who reached detectable PSA, 79% had progression within 7 years. On multivariate Cox proportional hazards regression, BGM status was not independently associated with detectable PSA, BCR and/or progression from detectable PSA to BCR or salvage treatment. CONCLUSIONS: The presence of BGM at RP was not associated with increased risk of MSM, detectable PSA, BCR or progression after detectable PSA.
引用
- Greenberg SA, Washington SL, Lonergan PE, et al. Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen. J Urol. 2021. PMID: 33905262. doi:10.1097/JU.0000000000001793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。